Largest biotech companies by net assets

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

ImmunityBio has the lowest figure of the 24 biotech companies ranked by net assets, at -NZ$910.9M, followed by Halozyme Therapeutics (NZ$88.8M) and Kodiak Sciences (NZ$286.5M). Figures as of 18 Nov 2026, 17:47 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
Lowest
ImmunityBio-NZ$910.9M
Median
NZ$3.7B
Combined market value
NZ$1.53T
Countries
5

Market values as of .

All countries
All sectors
Biotech
NZD
Clear filters
Largest biotech companies by net assets
#CompanyNet assets ↑Market capPriceToday1 yearPrice, 30 daysCountry
1ImmunityBioIBRX · Health Care-NZ$910.9MNZ$13BNZ$12.25 7.51% up 193% up United States
2Halozyme TherapeuticsHALO · Health CareNZ$88.8MNZ$20.1BNZ$176.02 0.77% up 37% up United States
3Kodiak SciencesKOD · Health CareNZ$286.5MNZ$11.6BNZ$177.79 0.91% up 396% up United States
4Adaptive BiotechnologiesADPT · Health CareNZ$398.2MNZ$8.4BNZ$52.18 0.63% up 88% up United States
5Scholar Rock HoldingSRRK · Health CareNZ$446.8MNZ$10.5BNZ$86.16 5.01% up 14% up United States
6Twist BioscienceTWST · Health CareNZ$860.8MNZ$14.6BNZ$214.37 5.16% up 340% up United States
7CG OncologyCGON · Health CareNZ$1.4BNZ$13.3BNZ$148.53 3.38% up 85% up United States
8ImmunovantIMVT · Health CareNZ$1.6BNZ$12.7BNZ$61.21 1.26% up 43% up United States
9Krystal BiotechKRYS · Health CareNZ$2.2BNZ$16.9BNZ$571.42 5.16% up 46% up United States
10Kymera TherapeuticsKYMR · Health CareNZ$2.9BNZ$19BNZ$222.58 0.63% up 87% up United States
11Revolution MedicinesRVMD · Health CareNZ$3BNZ$63BNZ$291.24 1.64% down 131% up United States
12CRISPR TherapeuticsCRSP · Health CareNZ$3.5BNZ$7.4BNZ$76.59 4.81% up 21% down Switzerland
13RepligenRGEN · Health CareNZ$3.8BNZ$20.1BNZ$314.00 6.38% up 5% up United States
14Bio-TechneTECH · Health CareNZ$3.8BNZ$20.8BNZ$132.47 0.21% up 26% up United States
15ExelixisEXEL · Health CareNZ$3.9BNZ$30.7BNZ$125.91 0.99% up 63% up United States
16VaxcytePCVX · Health CareNZ$4.9BNZ$17BNZ$107.47 0.60% down 22% up United States
17Neurocrine BiosciencesNBIX · Health CareNZ$5.9BNZ$29.9BNZ$295.89 2.02% down 20% up United States
18QiagenQGEN · Health CareNZ$6.9BNZ$18.7BNZ$90.35 0.22% down 12% up Netherlands
19argenxARGX · Health CareNZ$13.3BNZ$108.3BNZ$1,722.01 0.15% down 4% up Belgium
20ModernaMRNA · Health CareNZ$15.7BNZ$149.4BNZ$369.20 1.91% down 755% up United States
21AmgenAMGN · Health CareNZ$15.8BNZ$439.5BNZ$812.60 2.50% down 34% up United States
22BiogenBIIB · Health CareNZ$33.2BNZ$67.8BNZ$458.72 0.49% up 49% up United States
23BioNTechBNTX · Health CareNZ$38.8BNZ$38BNZ$153.23 0.79% down 16% down Germany
24Gilead SciencesGILD · Health CareNZ$41.3BNZ$382.2BNZ$308.12 0.57% down 33% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.8201 NZD).

Questions and answers

Which biotech companies have the lowest net assets?

ImmunityBio (-NZ$910.9M), Halozyme Therapeutics (NZ$88.8M) and Kodiak Sciences (NZ$286.5M) have the lowest net assets of the 24 biotech companies ranked here as of 18 Nov 2026, 17:47 UTC.

How many biotech companies are in this ranking?

24 are ranked by net assets.

What are these biotech companies worth together?

The 24 biotech companies ranked by net assets have a combined market value of NZ$1.53T as of 18 Nov 2026, 17:47 UTC.

What does ranking by net assets measure?

Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.

Cite this page

Funkfolio, “Largest biotech companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets

Underlying data: Yahoo Finance; SEC EDGAR.